Creo Medical Limited, based in Chepstow, South Wales develops innovative medical devices. Creo Medical’s unique bipolar radiofrequency and microwave energy platform enables precise tissue effects to be created with a range of clinically relevant instruments. The first instrument performs flexible endoscopic dissection of tissue abnormalities within the gastrointestinal tract. The initial range of instruments will provide a suite of gastroenterology products treating various complications via a flexible endoscope. The CROMA platform and product range will evolve into other areas of treatment such as laparoscopic surgery and treatment of certain cancerous lesions.
Monmouthshire, GB
Size (employees)
28 (est)+17%
Creo Medical was founded in 2009 and is headquartered in Monmouthshire, GB
Report incorrect company information

Creo Medical Office Locations

Creo Medical has an office in Monmouthshire
Show all (1)
Report incorrect company information

Creo Medical Financials and Metrics

Creo Medical Financials

Creo Medical's revenue was reported to be £277.69 k in FY, 2017

Revenue (FY, 2017)

277.7 k

Net income (FY, 2017)

(6.9 m)

EBITDA (FY, 2017)

(7.8 m)

EBIT (FY, 2017)

(7.9 m)

Market capitalization (31-Oct-2017)

23.1 m

Closing share price (31-Oct-2017)


Cash (30-Jun-2017)

284.3 k
Creo Medical's current market capitalization is £23.1 m.
GBPFY, 2008FY, 2016FY, 2017


410.7 k169.4 k277.7 k

Cost of goods sold

32.3 k

Gross profit

378.4 k

Gross profit Margin, %

GBPFY, 2008FY, 2016FY, 2017

Net Income

100.8 k(2.4 m)(6.9 m)

Cash From Operating Activities

(3.1 m)

Cash From Financing Activities

5.5 m

Net Change in Cash

2.3 m
GBPY, 2017


11.3 k

Financial Leverage

-0.5 x
Show all financial metrics
Report incorrect company information